Parathyroidectomy Improves the Consumption of Erythropoiesis-Stimulating Agents in Hemodialysis Patients

Secondary hyperparathyroidism (SHPT) is common in end-stage renal disease (ESRD) patients, and it can suppress erythropoiesis. We aimed to investigate the relationship between the consumption of erythropoiesis-stimulating agents (ESAs) and parathyroidectomy (PTX) in ESRD patients with SHPT and to de...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yu-Ting, Tu, Chi-Wen, Kam, Kam-Hong, Ma, Tsung-Liang, Kuo, Chin-Ho, Lee, Ming-Yang, Hsiao, Chih-Yen, Chan, Michael W. Y., Hung, Peir-Haur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499136/
https://www.ncbi.nlm.nih.gov/pubmed/36142295
http://dx.doi.org/10.3390/ijms231810391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499136/
https://www.ncbi.nlm.nih.gov/pubmed/36142295
http://dx.doi.org/10.3390/ijms231810391

Ejemplares similares